These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8963415)

  • 1. Presumed ocular myasthenia and micropsia. A case report.
    Michaeli-Cohen A; Almog Y; Loewenstein A; Stolovitch C; Gutman I; Lazar M
    J Neuroophthalmol; 1996 Mar; 16(1):18-20; discussion 21-2. PubMed ID: 8963415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferior oblique muscle paresis as a sign of myasthenia gravis.
    Almog Y; Ben-David M; Nemet AY
    J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An atypical course of myasthenia gravis.
    Labana SS; Qureshi S; Nandakumar T; Cervellione KL; Venkatraman GK; Thakore H; Gintautas J
    Proc West Pharmacol Soc; 2007; 50():140-2. PubMed ID: 18605252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of thyroid associated ophthalmopathy with myasthenia Graves in 12 patients].
    Ji H; Yang J; Zhu H; Jiang W; Sun F
    Zhonghua Yan Ke Za Zhi; 2015 Aug; 51(8):581-5. PubMed ID: 26696574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures.
    Yoo YJ; Han SB; Yang HK; Hwang JM
    Optom Vis Sci; 2018 May; 95(5):475-478. PubMed ID: 29683988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid eye movements in myasthenia gravis. I. Clinical observations.
    Cogan DG; Yee RD; Gittinger J
    Arch Ophthalmol; 1976 Jul; 94(7):1083-5. PubMed ID: 938289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of extra-ocular muscle involvement in ocular myasthenia.
    Cleary M; Williams GJ; Metcalfe RA
    Strabismus; 2008; 16(1):11-8. PubMed ID: 18306117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Low-to-Moderate Dose Oral Corticosteroid Treatment in Ocular Myasthenia Gravis.
    Lee YG; Kim US
    J Pediatr Ophthalmol Strabismus; 2018 Sep; 55(5):339-342. PubMed ID: 30074608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Tensilon-Negative Ocular Myasthenia Gravis By Daily Selfie.
    Guterman EL; Botelho JV; Horton JC
    J Neuroophthalmol; 2016 Sep; 36(3):292-3. PubMed ID: 27529328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: diagnostic mimics.
    Engstrom JW
    Semin Neurol; 2004 Jun; 24(2):141-7. PubMed ID: 15257510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis.
    Itoh H; Shibata K; Nitta S
    Br J Anaesth; 2001 Dec; 87(6):885-9. PubMed ID: 11878691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ocular symptoms in myasthenia gravis.
    Bhanushali MJ; Wuu J; Benatar M
    Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia. Multiple recurrences and spontaneous remissions.
    Hochman MS
    JAMA; 1982 Jan; 247(1):62. PubMed ID: 7053445
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular and systemic myasthenia gravis.
    Rodgin SG
    J Am Optom Assoc; 1990 May; 61(5):384-9. PubMed ID: 2355167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Ocular Myasthenia Gravis.
    Cornblath WT
    Asia Pac J Ophthalmol (Phila); 2018; 7(4):257-259. PubMed ID: 30044061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.